The method of establishing a priority-scoring model for thyroid carcinoma surgery admission_Chinese Journal of Evidence-Based Medicine

Authors：

LI Pengyu ¹ , ZHAO Wanjun ¹ , LI Zhihui ¹ ,  WEI Tao ¹ , SHEN Wenwu ²

1. Department of Thyroid Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
2. Party Committee Office of West China Hospital, Sichuan University, Chengdu 610041, P. R. China;

Corresponding author：

WEI Tao, Email: surgeonwei@163.com

Keywords：

Thyroid carcinoma; Admission priority-scoring model; Admission management

DOI：

10.7507/1672-2531.202112112

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To explore a method for establishing a priority-scoring model for thyroid carcinoma patient admission. Methods A questionnaire survey was conducted among specialists and outpatients in the thyroid surgery department of the hospital. The weight coefficient of the index factors was calculated to establish the priority-scoring mode by the analytic hierarchy process. The differences in results between specialists and patients were compared. The logical rationality of the model index was tested. Results A priority-scoring model for thyroid carcinoma surgery admission was established, including 10 first-level indicators, such as sex, age, cancer type and TNM stage. The weight coefficients of the indicators from high to low were cancer type (0.137), TNM stage (0.134), tumor size (0.127), tumor invasion degree (0.126), tumor invasion site (0.124), relationship between tumor and capsule (0.111), age (0.093), sex (0.061), place of residence (0.05) and medical insurance type (0.035). After the total ratio test, the model CR value was 0.0073, and the model index was highly rational. Conclusion This study successfully establish a priority-scoring model for thyroid carcinoma surgery admission, which can provide references and a basis for tiered medical services and relevant researches in the future.

Citation： LI Pengyu, ZHAO Wanjun, LI Zhihui, WEI Tao, SHEN Wenwu. The method of establishing a priority-scoring model for thyroid carcinoma surgery admission. Chinese Journal of Evidence-Based Medicine, 2022, 22(6): 628-633. doi: 10.7507/1672-2531.202112112 Copy

1.	申文武, 廖成成, 罗利, 等. 大型综合医院患者分层级入院优先级决策的评价指标体系构建研究. 现代预防医学, 2018, 45(8): 1424-1427.
2.	申文武. 从外循环到内循环破解出入院服务困局. 现代医院管理, 2017, 15(1): 2-4.
3.	张洁, 闫贻忠, 王丹, 等. 2005-2014年中国肿瘤登记地区甲状腺癌发病的时间趋势分析. 现代预防医学, 2020, 47(4): 577-582,591.
4.	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
5.	Misiak D, Bauer M, Lange J, et al. MiRNA deregulation distinguishes anaplastic thyroid carcinoma (ATC) and supports upregulation of oncogene expression. Cancers (Basel), 2021, 13(23): 5913.
6.	Luo H, Xia X, Kim GD, et al. Characterizing dedifferentiation of thyroid cancer by integrated analysis. Sci Adv, 2021, 7(31): eabf3657.
7.	Mihalopoulos C, Carter R, Pirkis J, et al. Priority-setting for mental health services. J Ment Health, 2013, 22(2): 122-134.
8.	Oudhoff JP, Timmermans DR, Rietberg M, et al. The acceptability of waiting times for elective general surgery and the appropriateness of prioritising patients. BMC Health Serv Res, 2007, 7: 32.
9.	MacCormick AD, Plank LD, Robinson EM, et al. Prioritizing patients for elective surgery: clinical judgement summarized by a Linear Analogue Scale. ANZ J Surg, 2002, 72(9): 613-617.
10.	Ceschia S, Schaerf A. Modeling and solving the dynamic patient admission scheduling problem under uncertainty. Artif Intell Med, 2012, 56(3): 199-205.
11.	Meyer T, Raspe H. Priority setting: what is it all about, and how does it work. Rehabilitation (Stuttg), 2012, 51(2): 73-80.
12.	Capdevila J, Wirth LJ, Ernst T, et al. PD-1 blockade in anaplastic thyroid carcinoma. J Clin Oncol, 2020, 38(23): 2620-2627.
13.	Molinaro E, Romei C, Biagini A, et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol, 2017, 13(11): 644-660.
14.	Maniakas A, Dadu R, Busaidy NL, et al. Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000-2019. JAMA Oncol, 2020, 6(9): 1397-1404.
15.	Capdevila J, Mayor R, Mancuso FM, et al. Early evolutionary divergence between papillary and anaplastic thyroid cancers. Ann Oncol, 2018, 29(6): 1454-1460.
16.	Haddad RI, Nasr C, Bischoff L, et al. NCCN guidelines insights: thyroid carcinoma, version 2. 2018. J Natl Compr Canc Netw, 2018, 16(12): 1429-1440.
17.	Huang SH, O'Sullivan B. Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol, 2017, 18(7): 40.
18.	Schmitz C, Rekowski J, Reinke S, et al. Metabolic tumor volume, cancer cell fraction, and prognosis-the case of T-cell/histiocyte-rich large B-cell lymphoma. Leuk Lymphoma, 2020, 61(6): 1372-1379.
19.	Murphy JD, La TH, Chu K, et al. Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys, 2011, 80(2): 514-521.
20.	Lee Y, Lee SH, Kim YJ, et al. Effects of a new medical insurance payment system for hospice patients in palliative care programs in Korea. BMC Palliat Care, 2018, 17(1): 45.
21.	Mao W, Tang S, Zhu Y, et al. Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China. Int J Equity Health, 2017, 16(1): 180.
22.	刘晓梅, 王艺臻. 商业医疗保险和社会医疗保险的责任定位研究. 东北财经大学学报, 2021, (6): 66-75.
23.	张振忠. 医保制度发展与公立医院改革. 中国卫生经济, 2022, 41(1): 1-5.
24.	曾彬. 甲状腺癌患者健康知识认知详情和需求分析. 广州医药, 2020, 51(3): 107-110.
25.	Solans-Domènech M, Adam P, Tebé C, et al. Developing a universal tool for the prioritization of patients waiting for elective surgery. Health Policy, 2013, 113(1-2): 118-126.
26.	MacCormick AD, Collecutt WG, Parry BR. Prioritizing patients for elective surgery: a systematic review. ANZ J Surg, 2003, 73(8): 633-642.
27.	Hong J, Eo EK, Shin SD, et al. Injury prevention priority setting based on the National Injury Surveillance data in Korea. Int J Inj Contr Saf Promot, 2011, 18(4): 285-291.
28.	Wiebe DJ, Nance ML, Branas CC. Determining objective injury prevention priorities. Inj Prev, 2006, 12(5): 347-350.
29.	Escobar A, Quintana JM, Espallargues M, et al. Different hip and knee priority score systems: are they good for the same thing. J Eval Clin Pract, 2010, 16(5): 940-946.

1. 申文武, 廖成成, 罗利, 等. 大型综合医院患者分层级入院优先级决策的评价指标体系构建研究. 现代预防医学, 2018, 45(8): 1424-1427.
2. 申文武. 从外循环到内循环破解出入院服务困局. 现代医院管理, 2017, 15(1): 2-4.
3. 张洁, 闫贻忠, 王丹, 等. 2005-2014年中国肿瘤登记地区甲状腺癌发病的时间趋势分析. 现代预防医学, 2020, 47(4): 577-582,591.
4. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
5. Misiak D, Bauer M, Lange J, et al. MiRNA deregulation distinguishes anaplastic thyroid carcinoma (ATC) and supports upregulation of oncogene expression. Cancers (Basel), 2021, 13(23): 5913.
6. Luo H, Xia X, Kim GD, et al. Characterizing dedifferentiation of thyroid cancer by integrated analysis. Sci Adv, 2021, 7(31): eabf3657.
7. Mihalopoulos C, Carter R, Pirkis J, et al. Priority-setting for mental health services. J Ment Health, 2013, 22(2): 122-134.
8. Oudhoff JP, Timmermans DR, Rietberg M, et al. The acceptability of waiting times for elective general surgery and the appropriateness of prioritising patients. BMC Health Serv Res, 2007, 7: 32.
9. MacCormick AD, Plank LD, Robinson EM, et al. Prioritizing patients for elective surgery: clinical judgement summarized by a Linear Analogue Scale. ANZ J Surg, 2002, 72(9): 613-617.
10. Ceschia S, Schaerf A. Modeling and solving the dynamic patient admission scheduling problem under uncertainty. Artif Intell Med, 2012, 56(3): 199-205.
11. Meyer T, Raspe H. Priority setting: what is it all about, and how does it work. Rehabilitation (Stuttg), 2012, 51(2): 73-80.
12. Capdevila J, Wirth LJ, Ernst T, et al. PD-1 blockade in anaplastic thyroid carcinoma. J Clin Oncol, 2020, 38(23): 2620-2627.
13. Molinaro E, Romei C, Biagini A, et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol, 2017, 13(11): 644-660.
14. Maniakas A, Dadu R, Busaidy NL, et al. Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000-2019. JAMA Oncol, 2020, 6(9): 1397-1404.
15. Capdevila J, Mayor R, Mancuso FM, et al. Early evolutionary divergence between papillary and anaplastic thyroid cancers. Ann Oncol, 2018, 29(6): 1454-1460.
16. Haddad RI, Nasr C, Bischoff L, et al. NCCN guidelines insights: thyroid carcinoma, version 2. 2018. J Natl Compr Canc Netw, 2018, 16(12): 1429-1440.
17. Huang SH, O'Sullivan B. Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol, 2017, 18(7): 40.
18. Schmitz C, Rekowski J, Reinke S, et al. Metabolic tumor volume, cancer cell fraction, and prognosis-the case of T-cell/histiocyte-rich large B-cell lymphoma. Leuk Lymphoma, 2020, 61(6): 1372-1379.
19. Murphy JD, La TH, Chu K, et al. Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys, 2011, 80(2): 514-521.
20. Lee Y, Lee SH, Kim YJ, et al. Effects of a new medical insurance payment system for hospice patients in palliative care programs in Korea. BMC Palliat Care, 2018, 17(1): 45.
21. Mao W, Tang S, Zhu Y, et al. Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China. Int J Equity Health, 2017, 16(1): 180.
22. 刘晓梅, 王艺臻. 商业医疗保险和社会医疗保险的责任定位研究. 东北财经大学学报, 2021, (6): 66-75.
23. 张振忠. 医保制度发展与公立医院改革. 中国卫生经济, 2022, 41(1): 1-5.
24. 曾彬. 甲状腺癌患者健康知识认知详情和需求分析. 广州医药, 2020, 51(3): 107-110.
25. Solans-Domènech M, Adam P, Tebé C, et al. Developing a universal tool for the prioritization of patients waiting for elective surgery. Health Policy, 2013, 113(1-2): 118-126.
26. MacCormick AD, Collecutt WG, Parry BR. Prioritizing patients for elective surgery: a systematic review. ANZ J Surg, 2003, 73(8): 633-642.
27. Hong J, Eo EK, Shin SD, et al. Injury prevention priority setting based on the National Injury Surveillance data in Korea. Int J Inj Contr Saf Promot, 2011, 18(4): 285-291.
28. Wiebe DJ, Nance ML, Branas CC. Determining objective injury prevention priorities. Inj Prev, 2006, 12(5): 347-350.
29. Escobar A, Quintana JM, Espallargues M, et al. Different hip and knee priority score systems: are they good for the same thing. J Eval Clin Pract, 2010, 16(5): 940-946.

Chinese Journal of Evidence-Based Medicine

The method of establishing a priority-scoring model for thyroid carcinoma surgery admission

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content